EPKINLY is a treatment for adult patients with Relapsed or Refractory diffuse large B-cell lymphoma (R/R DLBCL) not otherwise specified, DLBCL transformed from indolent lymphoma, high grade B-cell ...

Two main types of lymphocytes exist: T cells and B cells. Diffuse Large B-cell Lymphoma (DLBCL) specifically involves the unchecked growth of B cells. This type of lymphoma is known for its rapid ...

Stanford Medicine researchers discovered a method to induce cancer cell death by manipulating proteins involved in apoptosis.

Lymphoma, a cancer of the immune system, is silently ravaging the health of Black men across America. This insidious disease, ...

India continues to see a steady rise in the incidence of lymphoma, the most common type of blood cancer. But among all the ...

AbbVie (NYSE: ABBV) today announced that nine provinces have provided accelerated public coverage of EPKINLY™. EPKINLY is a treatment for adult patients with Relapsed or Refractory diffuse large ...

A mouse xenograft model of DLBCL tumors was used to characterize the role of TNFAIP3 expression tumor growth. Tumors induced from cells with higher levels of TNFAIP3 had a lower volume compared with ...

Ladenburg analyst Aydin Huseynov raised the firm’s price target on Marker Therapeutics (MRKR) to $19 from $11 and keeps a Buy rating on the shares. Ladenburg is becoming more confident in seeing ...

Monday announced that nine provinces have approved accelerated public coverage of Epkinly, a treatment for adult ...